The 1,000 units mentioned for February took some time for them to get because they ran into some bumps, lack of financing, and had bills to pay between May and October. But that window is no doubt when the company showed the market they absolutely won't sell out to toxic/hard lending.
They achieved their 1,100 unit by December goal early in November after Doheny signed off on the loan in October for the manufacturing of 1,600 units and wired them funds I believe the same day.
After outperforming lender expectations, the loan was increased to manufacture an additional 600 units bringing the total loan to enough money to produce 2,200 units. That will bring their total count to 2,700.
The break down taken from filings is as follows:
Units/Date
225 January 2016
350 May
515 August
1,100 November
2,000 January 2017
2,700 On track for March
You can see the increases. They increased units almost 1,000% over the last 12 months. Their goal for this year is almost another 400%, aggressive but the market demand and what the company's shown the market they can handle so far indicate it's definitely doable.
Assets have gone from $75k to $465k between Dec and September and they're close to tripling units since November.
Their net has increase over 65% over 12 months and they went from a -.0332 eps to -.0093 in the same period with a positive eps knocking on the door.
Quarterly revenues went from $21,000 to $144,000 between Dec and Sept and their gross profit is up over 550%
Liabilities are trending lower as assets are growing.
I lost track of how many installation location contracts and exclusive referral contracts they have but they qualified for 11 state permits and have 2 or 3 franchises now.
I try to ignore their chatter about getting into mj breathalyzers, up listing, their other divisions, now they're looking for an acquisition, it's just noise until they show us the money or show us how they made the acquisition, hopefully without common shares.
But their numbers and growth speak for themselves in a fast growing market backed by highly increasing legislation.
I just don't like the share structure. There's no reason for 100 million authorized and 18.6 million outstanding now. They could cut it in half easily but haven't. Raises a flag in my opinion.
But the SC-13G filed on Jan 23rd shows the o/s decreased by 1.7 million shares. Would be a nice start if it's accurate and they update us.
I'm a non-professional individual investor who may own, not own, buy, or sell stock at any given time in any security ever mentioned in posts. I never accept compensation in any form to post. Always consult an investment professional when investing.
Recent LTES News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:07:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/28/2023 12:47:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 12:13:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/06/2023 06:06:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:37:34 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM